Breast Implants Market by Implant Type (Silicone
Implant and Saline Implant), Application (Breast Reconstruction and Breast
Augmentation), End User (Hospitals and Cosmetology Clinics) – Global Outlook
& Forecast 2021-2031
According to the deep-dive market assessment
study conducted by Growth+ Reports, the global breast implants market was pegged
at ~US$ 2.76 billion in 2020. The market is expected to witness a CAGR of ~10.7%
from 2021 to 2031.
Government bodies and various organizations across
the globe are taking several initiatives to fast-track the development of breast
implants by providing the necessary funding, grants, permissions, clearances, and
approvals. For instance, in February 2018, the health department of the South
Indian state Tamil Nadu launched free cosmetic surgery clinic at the Government
Stanley Medical College and Hospital which will provide free breast implants or
breast reconstruction surgeries to poor people. Government and regulatory
bodies are also working towards awareness about the complications of breast
implants. For instance, in Oct 2021, the U.S. Food and Drug Administration took
several new actions to strengthen breast implant risk communication and to ensure
that patients considering breast implants are provided with adequate risk
information so that they can make fully informed decisions.
Breast cancer arises in the lining cells
(epithelium) of the ducts (85%) or lobules (15%) in the glandular tissue of the
breast. Breast cancer is the second most common form of cancer among women in
the United States. It is a leading cause of cancer death in less developed
countries. In 2020, around 2.3 million women were diagnosed with breast cancer
and about 685,000 women died due to breast cancer globally. The death rate for breast
cancer is higher than those for any other cancer in U.S. women. Mastectomy is a
surgery to remove all breast tissue from a breast and is commonly adopted as a
way to treat or prevent the spread of breast cancer. After mastectomy, breast
implantation is the most common option used for breast reconstruction. In 2019,
around 107,000 breast reconstruction procedures were performed in the U.S., of
which 80% of procedures were performed using implants. Hence, the rising
incidence of breast cancer and increasing adoption of implantation after
mastectomy, are expected to boost the growth of the market.
Breast augmentation/augmentation mammoplasty is
a surgical procedure that aims to increase the size, change the shape, and
alter the texture of the breasts of a woman. Breast augmentation is a type of
cosmetic surgery performed mainly for esthetic purposes. According to 2017 data
published by the American Society of Plastic Surgeons (ASPS), breast
augmentation was the most frequently performed cosmetic surgical procedure
nationwide and constituted around 17% of the total plastic surgeries performed.
An increasing number of augmentation surgeries is expected to propel the growth
of the market.
However, complications
related to breast implants are expected to restrain the market growth to a
certain extent. Common complications associated with breast implants include infection,
chronic breast pain, rupturing or leaking of the implant, necrosis, and breast
or nipple numbness. Furthermore, among the patients who had undergone
reconstruction surgery, around 45% of patients with silicone gel implants and around
20% with saline implants underwent at least one additional operation within 3
years. Whereas, around 25% of patients with silicone implants and 8% of patients
with saline implants removed their implants. Therefore, complications associated
with implants and an increase in the overall cost due to these complications are
expected to limit the growth of the market.
The Asia
Pacific region is projected to be the fastest-growing breast implants market. The
high growth of the region can mainly be attributed to the developing healthcare
infrastructure, rising disposable income, changing lifestyles, and rising
prevalence of breast cancer. Countries such as India, China, and Japan in the
APAC region, are projected to offer significant growth opportunities owing to
the presence of a large population and the rising medical tourism in the region.
Some of the prominent players operating in the
breast implants market are AbbVie, Polytech Health &
Aesthetics GmbH, Johnson & Johnson Services, Inc., Sebbin, Sientra, Inc.,
GC Aesthetics, Silimed, Establishment Labs S.A., Ideal Implant Incorporated,
and Laboratoires Arion, among others.
Reach Us
